Reactions to withdrawal of antidepressants, antiparkinsonian drugs, and lithium.
Lawrence
J M
JM
D000928:Antidepressive Agents / Q000009:adverse effects*; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects; D000978:Antiparkinson Agents / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D001921:Brain / Q000378:metabolism; D003937:Diagnosis, Differential; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D008094:Lithium / Q000009:adverse effects*; D009069:Movement Disorders / Q000139:chemically induced; D018377:Neurotransmitter Agents / Q000378:metabolism; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis* / Q000378:metabolism; D019966:Substance-Related Disorders / Q000175:diagnosis
D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D000978:Antiparkinson Agents; D018377:Neurotransmitter Agents; D008094:Lithium